Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05578976 |
|---|---|
| Brief Title: | A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) (EPCORE DLBCL-2) |
| First Submitted : | October 12, 2022 |
| First Submitted that Met QC Criteria : | October 12, 2022 |
| First Posted : | October 13, 2022 |
| Last Update Submitted that Met QC Criteria : | May 6, 2024 |
| Last Update Posted : | May 7, 2024 |